IBM PET project tackles human fungal infections

PRW

Published: December 9, 2013 3:37 pm ET
Updated: December 9, 2013 3:39 pm ET

Related to this story

Topics Medical

Researchers from IBM and Singapore’s Institute of Bioengineering and Nanotechnology (IBN) have converted PET into a non-toxic and biocompatible drug delivery system designed to attack fungal infections.

The new antifungal agents self-assemble in the bloodstream through a hydrogen-bonding process to form nanofibers, which attach to fungal membranes using electrostatic attraction, according to a peer-reviewed paper published by Nature Comm. These then break through the membrane wall of the fungal cell, destroying its infective content.

According to Dr. Yi Yan Yang, the group leader at IBN, said: “The ability of these molecules to self-assemble into nanofibers is important because unlike discrete molecules, fibers increase the local concentration of cationic charges and compound mass. This facilitates the targeting of the fungal membrane and its subsequent lysis, enabling the fungi to be destroyed at low concentrations.”

Over a billion people are affected by fungal infections every year, ranging in severity from topical skin conditions like athlete’s foot to life-threatening fungal blood infections, claimed the research team. The infection is more likely to occur when the body’s immune system is compromised due to an illness such as HIV, cancer or when receiving antibiotic treatment.


Comments

IBM PET project tackles human fungal infections

PRW

Published: December 9, 2013 3:37 pm ET
Updated: December 9, 2013 3:39 pm ET

Post Your Comments


Back to story


More stories

Image

US pharma packaging worth $22 billion by 2018

September 8, 2014 1:14 pm ET

Demand for pharmaceutical packaging products in the United States is expected to increase by 4.9 percent annually and the value of the market reach...    More

Image

Tecomet buys implant manufacturing specialist

September 4, 2014 12:16 pm ET

WILMINGTON, MASS. — Tecomet Inc., a Wilmington company that makes orthopedic implants, has purchased 3D Medical Manufacturing Inc., Riviera...    More

Image

JV aimed at pharmaceutical and medical device packaging

September 4, 2014 12:10 pm ET

Mocon Inc. and Life Packaging Technology LLC have formed a joint venture aimed at improving time-to-market for pharmaceutical and medical device...    More

Image

Acquisition gives Sunningdale an injection molding footprint in India

September 3, 2014 10:29 pm ET

SINGAPORE — Injection molder and toolmaker Sunningdale Tech Ltd. on Sept. 3 announced plans to buy First Engineering Ltd., a manufacturer of...    More

Market Reports

Shale Gas Market - Analysis of North American Region

This report highlights the impact of shale-based natural gas on the North American plastics market and features an in-depth analysis of production trends in the United States during 2013 and a forecast for 2014 and beyond.

Learn more

Thermoformed Packaging 2014 Market Review & Outlook North America

This in-depth report analyzes economic and market trends, legislative/regulatory activity impacting supply and demand, business opportunities and threats, materials pricing, manufacturing technology, as well as growth strategies being implemented by thermoformed packaging companies.

Learn more

Pipe, Profile & Tubing Extrusion in North America 2014

U.S. demand for extruded plastics is expected to grow by 3 percent in 2014, with PVC remaining the largest segment.

Plastic pipe will post the strongest gains through 2018, continuing to take market share from competing materials in a range of markets.

Our latest market report provides in-depth analysis of current trends and their financial impact on the pipe, profile and tubing extrusion industry in North America.

Learn more

Upcoming Plastics News Events

January 14, 2015 - January 14, 2015Plastics in Automotive

February 4, 2015 - February 6, 2015Plastics News Executive Forum 2015

More Events